top of page
Researcher

PRIMAVERA

Start Date:

November 2021

End Date:

ongoing

Duration:

60 months

ID-CARE Role:
Website:

Partner

Description

GA Number: 101034420


Title: PrIMAVeRa  - Predicting the Impact of Monoclonal Antibodies & Vaccines on Antimicrobial Resistance


Primary Objectives: The goal of PrIMAVeRa is to develop comprehensive mathematical models to predict the impact of vaccines and monoclonal antibodies (mAbs) on the reduction of antimicrobial resistance (AMR), thereby enabling decision-makers to prioritise the most promising new vaccines and mAbs.

A sustainability plan will also be designed by the project partners with the goal to ensure long-term access to the project results, including models, beyond the duration of the PrIMAVeRa project.

The following main goals will be addressed in an integrated manner:

  • Assessment of the availability and quality of published data and existing mathematical models of AMR

  • Setting up a comprehensive epidemiological repository

  • Development of improved mathematical models of AMR including cost-effectiveness analyses (CEA)

  • Establishment of a plan for evaluation

Partners

Ares Genetics GmbH - AUSTRIA

Danmarks Tekniske Universitet - DENMARK

Eberhard Karls Universität Tübingen - DENMARK

European Vaccine Initiative (EVI) - DENMARK

GlaxoSmithKline Biologicals SA (GSK) - BELGIUM

Hospital of Lithuanian University of Health Sciences Kauno Klinikos - LITHUANIA

Institut Pasteur - FRANCE

Institute of Health Carlos III - SPAIN

Janssen Vaccines & Prevention B.V. - NETHERLANDS

Life Science Network gGmbH - DENMARK

Pasteur Institute of Russia - RUSSIA

Pfizer - UK

Public Health England - UK

Servicio Andaluz de Salud - SPAIN

Université Grenoble Alpes - FRANCE

University Medical Center Utrecht (UMC Utrecht) - NETHERLANDS

University of Geneva - SWITZERLAND

University of Oxford - UK

Sponsor
Horizon2020.jpg
Horizon2020.jpg
Horizon2020.jpg
Horizon2020.jpg
Publications

Clinical Microbiology and Infection

15/11/23

Frequency of bloodstream infections caused by six key antibiotic-resistant pathogens for prioritization of research and discovery of new therapies in Europe: a systematic review

Clinical Microbiology and Infection

4/10/23

A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe

ID-CARE Participants

Evelina Tacconelli

Director

Fabiana Arieti

Clinical Research Assistant & Project Manager

Benedetta Barana

Clinical Research Assistant

Maria Diletta Pezzani

Medical Doctor

Jacopo Garlasco

Research Assistant

Maria Elena De Rui

ID Resident

Eva Cappelli

Clinical Research Assistant

In the News
bottom of page